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Abstract 21 
Background The ability to predict and therefore avoid surgery in those patients likely to die 22 
from simultaneous renal and cardiac surgery for urological tumours involving the peri-23 
diaphragmatic vena cava and right atrium would be valuable. 24 
Objective To identify pre-operative factors that predict thirty-day mortality (TDM) in patients 25 
undergoing this type of surgery. 26 
Design setting and participants Retrospective review of peri-operative outcomes in patients 27 
managed between December 2007 and January 2016 by a single team.  28 
Outcome measurements and statistical analysis: Relationships with outcome analysed using 29 
Fisher’s Exact and Mann Whitney U tests. 30 
Results and Limitations: 46 patients of whom 41/46 (89%) underwent surgery  31 
20 males; 21 females . Median age 65 yrs (range 17-95). 37 renal cell cancer, 1 adrenal cancer, 2 32 
primitive neuroectodermal tumours and 1 leiomyosarcoma.  33 
Overall TDM 3/41 patients (7%). INR, age and eGFR correlated significantly with TDM.  34 
Mortality if INR >1.5,  3/5 (60%) compared to 0/36 (0%) if INR <1.5. 35 
Mortality if INR >1.5 and age >70 years 3/3 (100%) 36 
INR correlated with serious complications (≥Clavien 3) (INR>1.5: 5/5 (100%) vs INR<1.5:  12/36 37 
(33%); p<0.002). 38 
Median eGFR in those that died was 36 (range 26-37) compared to 52 (range 24-154) in those 39 
that survived (p=0.018). 40 
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Limitations include retrospective design  41 
Conclusions:  Combined cardiac and renal surgery is associated with high risk of TDM when the 42 
preoperative INR is abnormal and the patient is elderly. Surgery in patients with a normal INR is 43 
challenging but safer.  44 
Patient summary: When kidney tumours invade the inferior vena cava and the heart, blood 45 
coagulation may become very abnormal (raised INR). Simultaneous cardiac and renal surgery 46 
appears very high risk if the pre-operative INR is raised, particularly in the elderly. The surgery 47 
appears much safer if the pre-operative INR is normal. 48 
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Introduction 60 
Growth of renal cancer into the retro-hepatic IVC and onwards into the right atrium presents a 61 
considerable circulatory and oncological challenge. Patients may be very short of breath due to 62 
the circulatory compromise; venous return may be reduced; right atrial function sub-optimal; 63 
embolism of tumour may further impair cardio-pulmonary function; there may be very marked 64 
swelling of the abdomen and lower limbs limiting mobility; the mass of tumour itself may be 65 
enormous; and metastasis at the time of presentation is common. Nevertheless the situation is 66 
not hopeless and since the first reports of successful surgery in the 1970’s [1,2] there has been 67 
steady progress in our understanding of how best to manage the various challenges associated 68 
with intra-caval and intra-cardiac renal cancer. When the tumour is in the right atrium the 69 
combination of radical nephrectomy with intra-cardiac and retro-hepatic intravenous tumour 70 
extraction under conditions of hypothermic total circulatory arrest on cardiopulmonary bypass 71 
is one approach [3-6]. There does however continue to be debate about the necessity for 72 
hypothermic arrest and even bypass in these situations, particularly when the cephalad extent 73 
of venous invasion is supra-hepatic but not atrial [7]. Expert multidisciplinary intra-operative 74 
care from cardiothoracic surgeons, cardiothoracic anaesthetists, and urologists combined with 75 
post-operative intensive care allows the surgery to be performed with acceptable morbidity 76 
and mortality [8]. Nevertheless this combination remains one of the highest risk procedures in 77 
urological surgery with contemporary series reporting thirty-day mortality (TDM) of 78 
approximately 11% [6].  79 
Understanding who is most at risk of TDM would be a major step forward in the management 80 
of this condition. The surgery could then be offered selectively to those most likely to gain 81 
benefit from it. Other patients who were considered unlikely to survive the surgery or its 82 
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aftermath might be better managed with drugs or palliative approaches. This would also mean 83 
that this very expensive care could be concentrated on those likely to derive benefit from it. 84 
The question of who to offer surgery to has been made more pertinent by the introduction of 85 
drugs which are active in renal cancer [9]. This is for two reasons viz, firstly, the drugs may be 86 
an alternative to surgery altogether; and secondly, the drugs make control of metastatic 87 
disease a possibility thus opening up the whole field of complex intra-cardiac surgery in more 88 
advanced oncological situations or even cytoreductive settings.   89 
Abel et al [6] in a recent multicentre collaborative review of outcomes from several centres in 90 
the USA highlighted performance status and serum albumin as key determinants of peri-91 
operative outcomes although neither could absolutely discriminate between those destined to 92 
die from complications arising from surgery and those destined to do well. Other recent reports 93 
suggest that the surgical Apgar score [10] may help identify patients at high risk of 94 
complications post-nephrectomy.  The ideal test would be one that could be applied pre-95 
operatively and would be both highly sensitive and specific for predicting adverse peri-96 
operative outcomes.  97 
In 2007 we established a programme in our hospitals for the management of these complex 98 
intra-cardiac renal tumours. Two urological surgeons and one cardiothoracic surgeon and one 99 
cardiothoracic anaesthetist have been part of the core surgical team.  Our approach since 100 
inception of the programme has been inclusive, i.e. to err on the side of offering surgery rather 101 
than selecting out only lower risk candidates, often because surgery seemed to represent a 102 
patients only hope and because patients were often so symptomatic from the disease burden. 103 
In that time 46 patients have been referred to our team; 41 patients have undergone surgery, 104 
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and only 5 patients have been managed in other ways.  Now in 2016 we report the key lessons 105 
we have learned over that 8 year period regarding peri-operative risk.   106 
 107 
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Methods 123 
This study is a review of peri-operative outcomes and TDM in all patients who have undergone 124 
simultaneous cardiac and renal tumour surgery between December 2007 and May 2015 at our 125 
centre. A full review of electronic and paper records was undertaken. All operative records had 126 
been filed prospectively.  127 
The surgery was performed in the cardiothoracic units of St Thomas Hospital or London Bridge 128 
Hospital. The core team has comprised two urological surgeons, one cardiothoracic surgeon 129 
and one cardiothoracic anaesthetist. Patients underwent general anaesthesia; position was 130 
supine; incision median sternotomy with Mercedes Benz extension to the abdomen; early 131 
ligation of renal artery; full renal mobilisation; full mobilisation of right hepatic lobe; IVC 132 
mobilisation with division of caudate lobe branches; heparinisation and establishment of 133 
cardiopulmonary bypass with cooling to 22C and circulatory arrest for ~20minutes (if required); 134 
complete removal of tumour; IVC repair/grafting (if required); re-establishment of circulation; 135 
warming to 37C; wound closure. Patients were admitted either to overnight theatre recovery or 136 
intensive care at the discretion of the team.  137 
A number of potentially important pre and peri-operative variables were studied. These were 138 
then compared between patients who survived and patients who died in the perioperative 139 
period (30 days). Significance was determined using the Fisher’s Exact or Mann Whitney U-test. 140 
As there were only three peri-operative deaths, non-parametric logistic regression was used to 141 
identify which of these variables were statistically significantly associated with TDM. With 142 
respect to INR, no further stratification or adjustments were made due to the occurrence of 143 
quasi-complete and complete separation.  144 
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Complications were categorised according to the Clavien Dindo classification [11]. A secondary 145 
univariate analysis was performed to identify potential risk factors for serious complications 146 
(Clavien ≥3). Multivariate models were not possible due to the occurrence of quasi-complete 147 
and complete separation.  148 
 149 
 150 
 151 
 152 
 153 
 154 
 155 
 156 
 157 
 158 
 159 
 160 
 161 
 162 
163 
 9 
Results 164 
46 patients were assessed. 41/46(89%) underwent simultaneous urological and cardiac surgery. 165 
5 patients did not undergo surgery (1 refused, 3 overwhelming metastatic load, 1 extreme 166 
frailty). 34/41 (83%) operations were performed with curative intent in the absence of 167 
radiological evidence of metastases. 7/41 (17%) cytoreductive. 3/41(7%) patients died in the 168 
perioperative period. Histology: 35 clear cell RCC; 2 papillary RCC; 1 adrenocortical carcinoma; 2 169 
primitive neuroectodermal tumour; 1 leiomyosarcoma. 170 
Operative details are outlined in table 1. Post-operative complications are detailed by Clavien-171 
Dindo classification in table 2. Overall, 30/41 (73%) patients had complications. 17 of these 172 
were ≥Clavien 3 complications including 4 returns to theatre for bleeding and 1 for gastric 173 
perforation; 4 patients developed pulmonary emboli in the post-operative period and 4 174 
developed fast atrial fibrillation.  175 
Baseline characteristics of those that died and those that survived are compared in Table 3. 176 
INR, age and estimated glomerular filtration rate (eGFR) were the only pre-operative variables 177 
that were statistically significantly associated with TDM. When conducting non-parametric 178 
logistic regression for INR (INR ≥1.5 vs <1.5) and perioperative death, we found an odds ratio 179 
(OR) of +∞ (95%CI: 4.04 - +∞) with a p-value of 0.001. Even though the occurrence of quasi-180 
complete separation did not allow us to estimate the actual OR or the upper limit of the 95% CI, 181 
the lower limit of 4.04 indicates a strong positive association between an INR≥1.5 and risk of 182 
TDM. As a result, no further adjustments for age or eGFR could be made. 183 
 184 
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Despite preoperative correction of INR, all 5 patients (100%) who had raised pre-operative INR 185 
had serious complications (≥ Clavien 3) (1 Clavien 3b, 1 Clavien 4b, 3 Clavien V), compared to 186 
12/36(33%) of patients with normal INR (p<0.002; table 2). The mortality for those with a raised 187 
INR ≥1.5 was 3/5(60%) compared to 0/36 (0%) if the INR was normal. All 3 patients with a 188 
raised INR who died were aged ≥70 years. 5/8(62%) patients aged ≥70 years survived; all five 189 
had a normal INR.  190 
A similar non-parametric logistic regression model was conducted for serious complications as 191 
INR was the only risk factor showing an association in a multivariate analysis (table 4). When 192 
conducting a non-parametric logistic regression for INR (INR > 1.5 vs ≤ 1.5) and Clavien ≥3, we 193 
found an OR of +∞ (95%CI: 1.51 - +∞), with a P-value of 0.008. Even though the occurrence of 194 
quasi-complete separation did not allow us to estimate the actual OR or the upper limit of the 195 
95%CI, the lower limit of 1.51 indicates a positive association between an INR≥1.5 and risk of 196 
serious complications.  197 
The positive predictive value (PPV) of raised INR alone for death is 3/5 (60%). PPV of age ≥70 198 
years is 3/8 (37.5%). PPV for combination of age ≥70 years and INR ≥1.5 was 3/3 (100%). None 199 
of the 36 patients with a normal INR died. Negative predictive value (NPV) of normal INR 100% 200 
Bloods loss; the use of cardiac bypass with or without arrest and cooling; whether the tumour 201 
was above or below the diaphragm; abnormal liver profiles and albumin level; and performance 202 
status were not statistically significantly associated with TDM. 203 
 204 
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 206 
 11 
Discussion 207 
Surgery for patients with renal tumours invading the peri-diaphragmatic IVC and/or right atrium 208 
is high risk. This study suggests that surgery of this type is potentially dangerous if a patient’s 209 
pre-operative INR is abnormal. All 3 patients who died had an abnormal INR, despite the INR 210 
being corrected prior to surgery. The overall thirty-day mortality (TDM) in patients with INR 211 
≥1.5 was 3/5(60%). The two patients with INR ≥1.5 who survived had serious complications 212 
(Clavien 3b and 4b) and prolonged lengths of stay (62 and 70 days).  Furthermore, this study 213 
has shown that this surgery can be performed relatively safely in patients with normal INR. No 214 
patients with a normal INR died in the post-operative period (TDM 0%).  215 
It is of interest that the three patients who died in this series not only had an abnormal INR, but 216 
were also aged over 70, whereas the two patients with an abnormal INR who survived surgery 217 
were aged under 70 (aged 63 and 54 years). No patient over the age of 70 with an abnormal 218 
pre-operative INR >1.5 has survived. Put another way, the PPV for TDM of the combination of 219 
raised INR and age over 70 is 100%. This is important as it would suggest that elderly patients 220 
who are already showing signs of metabolic compromise by virtue of raised INR do not have the 221 
physiological reserve to survive the peri-operative challenge. The scale of the physiological 222 
challenge must be the same in younger patients, but they may have more physiological reserve 223 
to withstand it.  224 
Age and eGFR were also shown to be important determinants of risk. An obvious question to 225 
ask is, which is the most important risk factor– the INR, the eGFR or the age? Our data would 226 
suggest very strongly the INR. All five patients over the age of 70 who had normal INR survived. 227 
Furthermore, both younger patients with abnormal INR had very stormy post-operative 228 
periods. With respect to eGFR, the median eGFR of those who survived was 52 compared to 36 229 
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in those who died. All three patients who died had an eGFR <40 and overall the mortality in 230 
patients with an eGFR <40 was 3/8 (37.5%). Patients with a low GFR may be at increased risk of 231 
peri-operative death. Constraints of time in the pre-operative period precluded formal 232 
measurement of GFR (e.g. with chromium 51 labelled EDTA GFR) but might be of interest to 233 
investigate this association further. 234 
The reason the INR becomes abnormal in these patients is likely to be complex but probably 235 
due to hepatocellular dysfunction arising as a consequence of congestion as a result of partial 236 
hepatic venous obstruction. This in turn leads to ischaemia of parenchymal cells and deranged 237 
production of clotting factors [12}. Alterations to coagulation parameters in these patients 238 
seem to be a sign of advancing liver disease. Approximately 50% of our patients have abnormal 239 
pre-operative liver enzymes (AST, ALT, Alkaline phosphatise) presumably indicating mild liver 240 
dysfunction, but only 12% of these patients had progressed to have abnormal INR.  It is also 241 
interesting that despite all the patients with abnormal pre-operative coagulation having 242 
aggressive pre-procedure corrective measures with vitamin K and fresh frozen plasma 243 
infusions, major complications still transpired. The abnormalities signalled by a raised INR are 244 
probably far more complex than those simply of coagulation; and rather indicate a metabolic 245 
disorder which remains largely uncorrected despite the normalisation of coagulation. Equally 246 
interestingly, the hepatic venous obstruction leading to the abnormal INR is not always 247 
associated with clinical manifestations of the Budd-Chiari syndrome [12,13].  Only two of the 248 
five patients with an abnormal INR had a clinical Budd-Chiari syndrome as evidenced by ascites. 249 
None of the patients were jaundiced or encephalopathic.  250 
 251 
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Should patients with an abnormal INR not be offered this type of surgery? Based on this study 252 
we would exercise caution if the patient is elderly - as all three patients who had a raised INR 253 
and were aged over 70 years died (mortality 100%). In younger patients with an abnormal INR, 254 
we would still consider surgery if their background health was good prior to the tumour 255 
presentation, and particularly if the patient was very symptomatic from the circulatory 256 
disturbance; serious complications and a challenging post-operative period might be expected. 257 
Furthermore, our work should not be viewed in isolation. Abel et al [6] suggested performance 258 
status and serum albumin were also important factors associated with peri-operative 259 
complications and TDM. In our series performance status (PS) was not statistically significantly 260 
associated with TDM and deranged INR was a far more accurate predictor of mortality.  We 261 
speculate that reverse causation might explain why PS is not significantly associated with death 262 
– rather than a reflection of underlying co-morbidity, poor PS may be a direct consequence of 263 
circulatory obstruction or tumour volume, and therefore reversible with surgical correction. It 264 
should also be noted that in the Abel series albumin levels were only available on 50% of the 265 
patients making it difficult to be certain of the significance of the effect. One strength of our 266 
study is that INR is available on all our patients.  267 
This study is also very encouraging in demonstrating that combined cardiac and renal surgery 268 
can be performed in patients with a normal INR with a low risk of TDM. None of our 36 patients 269 
died. This may be valuable for optimising multidisciplinary clinical decision-making and for 270 
counselling patients pre-procedure. The majority of patients despite feeling ill, having 271 
compromised circulation and dyspnoea on exertion, and a large volume of tumour can be 272 
steered through surgery successfully and have much to gain symptomatically from correction of 273 
the circulatory problem. Nonetheless, the surgical and anaesthetic challenges are considerable 274 
 14 
and success is only possible with a well-organised highly committed skillful team. In the context 275 
of this disease this is also a high volume team. 276 
Despite overall TDM being low, complications are common in this group. Overall complications 277 
occurred in 30/41(73%) with 17/41(42%) having ≥Clavien 3 complications. Even in the group we 278 
would now consider relatively low risk for peri-operative death (normal INR, <70yrs), the 279 
complication rate was still 20/31(64%). INR appears to be a risk factor for predicting serious 280 
complications (Clavien ≥3) as well as TDM.  281 
This report is not considering the long-term oncological outcomes in this group of patients, but 282 
it is known that the majority of patients with locally advanced renal cancer of this type will 283 
develop systemic relapse [14,15].  The advent of multiple new medications for the control of 284 
metastatic disease does, however, offer hope to patients if their heavily symptomatic loco-285 
regional disease can be controlled [16]. A particularly difficult scenario is to know whether this 286 
type of surgery should be offered in cytoreductive settings [17,18]. A heavy burden of 287 
metastatic disease would in most instances disqualify a patient, but a low volume of metastatic 288 
disease in a younger patient, who has a normal INR and who is symptomatic from the 289 
circulatory disturbance, might be considered a reasonable candidate for cytoreductive surgery.  290 
The main limitation of this study is size making it difficult to draw stronger conclusions. 291 
However given the frequency of this tumour our single institution data is still clinically 292 
informative. Future study of the association between INR and TDM across wider groups of 293 
patients, and particularly in national audits of nephrectomy [19], may provide a larger number 294 
of events allowing for the calculation of multivariate logistic regression models. Moreover, our 295 
data can now inform sample size calculations for these future studies.  296 
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Conclusion 297 
In patients undergoing simultaneous renal and cardiac surgery for renal cancer, a raised pre-298 
operative INR appears to be a predictor of thirty-day mortality in elderly patients (≥70 years) 299 
and of significant post-operative complications in younger patients (<70 years). The surgery can 300 
be offered with more confidence to patients with a normal INR.   301 
 302 
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Tables 387 
 388 
Table 1. Operative details (n=41) 
  
Cardiac bypass 31 (76%) 
Arrest + cooling 27 (66%) 
Median blood loss in mls (min-max) 2250 (300-20000) 
Median Operation time in hours (min-max) 5 (2.25-7.5) 
Median length of stay in days (min-max) 16 (7-97) 
  
 389 
Table 2. Complications by INR   
 INR < 1.5 (n=36) INR ≥ 1.5 (n=5) P value 
Clavien-Dindo Classification   0.002 
0 11 (31) 0 (0)  
1 2 (6) 0 (0)  
2  11(31) 0 (0)  
3a 6 (17) 0 (0)  
3b 2 (6) 1 (20)  
4a 3 (8) 0 (0)  
4b 1 (3) 1 (20)  
5 0 (0) 3 (60)  
 390 
 391 
Table 3. Risk factors for serious complications 
 Clavien <3 (n=24) Clavien ≥3 (n=17) P-value 
Median age (min-max) 64.73 (31.00-95.00) 68.00 (17.00-76.00) 0.584 
Sex   0.086 
 20 
Male  9 (37.50) 11 (64.71)  
Female 15 (62.50) 6 (35.29)  
Karnofsky performance status   0.258 
20 0 (0.00) 2 (11.76)  
30 0 (0.00) 1 (5.88)  
40 0 (0.00) 1 (5.88)  
50 2 (8.33) 2 (11.76)  
60 3 (12.50) 0 (0.00)  
70 6 (25.00) 5 (29.41)  
80 8 (33.33) 3 (17.65)  
90   0.258 
Symptomatic 11 (45.83) 10 (58.82) 0.412 
Curative 18 (75.00) 16 (94.12) 0.109 
Above diaphragm 21 (91.30) 15 (88.24) 0.749 
Bypass 16 (66.67) 15 (88.24) 0.113 
Cooling 14 (58.33) 13 (76.47) 0.228 
Median EBL (min-max) 2000 (100-5000) 3000 (30-2000) 0.157 
Median Hb (min-max) 10.90 (10.00-87.00) 12.00 (9.00-13.00) 0.357 
Median CRP (min-max) 35.50 (26.00-49.00) 37.00 (5.00-312.00) 0.598 
Median INR (min-max) 1.00 (0.90-1.30) 1.00 (1.00-3.00) 0.033 
Abnormal LFTs 8 (33.33) 10 (58.82) 0.105 
Median albumin (min-max) 35.50 (26.00-49.00) 40.00 (26.00-50.00) 0.255 
Median creatinine (min-max) 95.00 (54.00-180.00) 111.00 (17.00-
368.00) 
0.235 
Median GFR (min-max) 52.50 (54.00-180.00) 46.00 (24.00-150.00) 0.910 
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